Mark Op den Winkel
Overview
Explore the profile of Mark Op den Winkel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lange S, Kruger N, Warm M, Op den Winkel M, Buechel J, Huber J, et al.
GMS J Med Educ
. 2022 Sep;
39(3):Doc34.
PMID: 36119150
Objective: Obtaining a systematic medical history (MH) from a patient is a core competency in medical education and plays a vital role in the diagnosis of diseases. At the Faculty...
2.
Klauss S, Op den Winkel M, Schirra J, Rentsch M, Mayerle J, Neumann J, et al.
Endoscopy
. 2022 Sep;
55(S 01):E3-E4.
PMID: 36049762
No abstract available.
3.
Angelberger M, Barnikel M, Fraccaroli A, Tischer J, Anton S, Pawlikowski A, et al.
Crit Care Res Pract
. 2022 Jun;
2022:5356413.
PMID: 35646396
Background: Percutaneous dilatational tracheostomy (PDT) has become the preferred method in several intensive care units (ICUs), but data on PDT performed in immunosuppressed and thrombocytopenic patients are scarce. This study...
4.
Op den Winkel M, Nagel D, Seidensticker M, De Toni E, Merz J, Op den Winkel J, et al.
Dig Dis
. 2022 Apr;
41(2):268-281.
PMID: 35421865
Introduction: In recent years, increasing options for systemic HCC treatment have become available. The development of therapy-specific prognostic scores has been encouraged. Tailoring therapy to individual patients requires prognostic scores...
5.
Reiter F, Ben Khaled N, Ye L, Zhang C, Seidensticker M, Op den Winkel M, et al.
Dig Dis
. 2021 Oct;
40(5):565-580.
PMID: 34644705
Background: Due to the number of emerging new treatment options, the systemic treatment of hepatocellular carcinoma (HCC) is rapidly changing. We provide here an overview of the current landscape of...
6.
Op den Winkel M, Nagel D, de la Torre Alaez M, Hempe S, De Toni E, Paprottka K, et al.
Dig Dis
. 2021 Jun;
40(3):322-334.
PMID: 34111866
Introduction: Selective internal radiation therapy (SIRT) is a local treatment option for patients with hepatocellular carcinoma (HCC). Its exact role next to other HCC therapies has yet to be defined....
7.
Koch C, Goller M, Schott E, Waidmann O, Op den Winkel M, Paprottka P, et al.
Cancers (Basel)
. 2021 Apr;
13(9).
PMID: 33924810
Background And Aims: Systemic treatment with sorafenib has been the standard of care (SOC) in patients with advanced Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC) for more...
8.
Fan Y, Du Z, Ding Q, Zhang J, Op den Winkel M, Gerbes A, et al.
Int J Oncol
. 2021 Apr;
58(6).
PMID: 33846777
Septin 6 (SEPT6) is a member of the GTP‑binding protein family that is highly conserved in eukaryotes and regulates various biological functions, including filament dynamics, cytokinesis and cell migration. However,...
9.
Op den Winkel M, Schirra J, Schulz C, De Toni E, Steib C, Anz D, et al.
Dig Dis
. 2021 Mar;
40(1):85-96.
PMID: 33684915
Background: In the setting of a naïve papilla, biliary cannulation is a key step in successfully performing endoscopic retrograde cholangiography. Difficult biliary cannulation (DBC) is associated with an increased risk...
10.
Kaiser R, Allgeier J, Philipp A, Mayerle J, Rothe C, Wallrauch C, et al.
BMC Gastroenterol
. 2020 Dec;
20(1):424.
PMID: 33317457
Background: Infection with Entamoeba histolytica and associated complications are relatively rare in developed countries. The overall low prevalence in the Western world as well as the possibly prolonged latency period...